paromomycin has been researched along with Anemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alcoba, G; Alnour, M; Atia, AM; Boulle, P; Chappuis, F; Elhag, MS; Mumina, A; Shah, S; Tayler-Smith, K; van Griensven, J; Zachariah, R | 1 |
| Baat, DB; Hassan, K; Hassan, M | 1 |
2 other study(ies) available for paromomycin and Anemia
| Article | Year |
|---|---|
Sodium stibogluconate and paromomycin for treating visceral leishmaniasis under routine conditions in eastern Sudan.
Topics: Adolescent; Adult; Anemia; Antimony Sodium Gluconate; Antiprotozoal Agents; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Infant; Leishmaniasis, Visceral; Lost to Follow-Up; Male; Malnutrition; Paromomycin; Patient Selection; Prevalence; Recurrence; Retrospective Studies; Sudan; Treatment Failure | 2015 |
A new breakthrough in treatment of visceral leishmaniasis in children.
Topics: Anemia; Animals; Anti-Bacterial Agents; Antiprotozoal Agents; Child; Child, Preschool; Female; Fever; Follow-Up Studies; Hepatomegaly; Humans; Infant; Injections, Intramuscular; Leishmania donovani; Leishmaniasis, Visceral; Leukocyte Count; Male; Pakistan; Paromomycin; Platelet Count; Splenomegaly | 1995 |